Back to Screener

CONMED Corporation (CNMD)

Price$33.06
Value ScoreA
Growth ScoreC
Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-35.41%
Price vs S&P 500 (4W)-12.56%
VGM Score56.28
Market Capitalization$1.02B
P/E Ratio (Annual)21.66x
Indicated Dividend Yield (Annual)2.36%

All Metrics

P/CF (Annual)5.97x
Book Value / Share (Quarterly)$33.76
P/TBV (Annual)2.79x
Indicated Dividend (Annual)$0.80
Revenue Growth (3Y)9.55%
Cash Flow / Share (Quarterly)$4.10
Payout Ratio (TTM)52.59%
Price vs S&P 500 (YTD)-28.01%
Gross Margin (TTM)55.17%
Net Profit Margin (TTM)4.00%
EPS (TTM)$1.77
10-Day Avg Trading Volume0.48M
EPS Excl Extra (TTM)$1.77
Revenue Growth (5Y)9.77%
EPS (Annual)$1.51
Dividend / Share (Annual)$0.80
ROI (Annual)2.52%
Gross Margin (Annual)53.87%
Net Profit Margin (5Y Avg)3.44%
Cash / Share (Quarterly)$1.16
P/E Basic Excl Extra (TTM)18.58x
Revenue Growth QoQ (YoY)-1.31%
EPS Growth (5Y)36.23%
P/E Normalized (Annual)21.66x
ROA (Last FY)2.02%
Revenue Growth TTM (YoY)4.14%
EBITD / Share (TTM)$4.76
ROE (5Y Avg)4.64%
Operating Margin (TTM)8.18%
Cash Flow / Share (Annual)$4.87
P/B Ratio1.00x
P/B Ratio (Quarterly)1.05x
Net Income / Employee (Annual)$12,100
EV / Revenue (TTM)1.35x
Net Interest Coverage (TTM)3.29x
ROA (TTM)2.36%
EPS Growth QoQ (YoY)133.02%
EV / EBITDA (TTM)12.53x
EPS Incl Extra (Annual)$1.51
Current Ratio (Annual)2.14x
Quick Ratio (Quarterly)0.90x
3-Month Avg Trading Volume0.48M
52-Week Price Return-38.88%
EV / Free Cash Flow (Annual)12.23x
P/E Incl Extra (TTM)18.58x
Revenue / Employee (TTM)$351,400
Tangible BV / Share (Quarterly)$14.73
P/S Ratio (Annual)0.74x
Asset Turnover (Annual)0.59x
52-Week High$60.35
Operating Margin (5Y Avg)8.01%
EPS Excl Extra (Annual)$1.51
CapEx CAGR (5Y)8.79%
Tangible BV CAGR (5Y)16.79%
26-Week Price Return-21.82%
Quick Ratio (Annual)0.92x
13-Week Price Return-26.08%
Total Debt / Equity (Annual)0.81x
Current Ratio (Quarterly)2.29x
Enterprise Value$1.85B
Revenue / Share Growth (5Y)8.58%
Asset Turnover (TTM)0.59x
Book Value / Share Growth (5Y)6.33%
Revenue / Employee (Annual)$352,500
Inventory Turnover (Annual)1.81x
Pretax Margin (Annual)5.17%
Cash / Share (Annual)$1.32
3-Month Return Std Dev40.49%
Gross Margin (5Y Avg)55.02%
Net Income / Employee (TTM)$14,100
EBITDA CAGR (5Y)11.35%
EBITDA Interim CAGR (5Y)3.74%
ROE (Last FY)4.55%
Net Interest Coverage (Annual)3.74x
EPS Basic Excl Extra (Annual)$1.51
P/FCF (TTM)8.24x
Receivables Turnover (TTM)6.09x
EV / Free Cash Flow (TTM)14.91x
Total Debt / Equity (Quarterly)0.85x
EPS Incl Extra (TTM)$1.77
Receivables Turnover (Annual)5.66x
ROI (TTM)2.93%
Dividend Growth Rate (5Y)0.10%
P/S Ratio (TTM)0.74x
Pretax Margin (5Y Avg)4.92%
Revenue / Share (Annual)$44.13
Tangible BV / Share (Annual)$14.56
Forward P/E7.74x
Free OCF CAGR (5Y)23.98%
Price vs S&P 500 (52W)-67.03%
P/E Ratio (TTM)18.58x
EPS Growth TTM (YoY)-53.87%
Year-to-Date Return-16.63%
5-Day Price Return-4.59%
EPS Normalized (Annual)$1.51
ROA (5Y Avg)2.12%
Net Profit Margin (Annual)3.42%
Month-to-Date Return-5.18%
Cash Flow / Share (TTM)$4.16
EBITD / Share (Annual)$4.42
Operating Margin (Annual)7.46%
LT Debt / Equity (Annual)0.81x
P/CF (TTM)7.15x
ROI (5Y Avg)2.59%
P/E Excl Extra (TTM)18.58x
LT Debt / Equity (Quarterly)0.85x
EPS Basic Excl Extra (TTM)$1.77
P/TBV (Quarterly)2.40x
Payout Ratio (Annual)52.59%
P/B Ratio (Annual)1.22x
Dividend / Share (TTM)$0.61
Inventory Turnover (TTM)1.70x
Pretax Margin (TTM)5.97%
Book Value / Share (Annual)$33.36
Price vs S&P 500 (13W)-36.74%
Net Margin Growth (5Y)25.47%
Dividend Yield (TTM)1.82%
Beta0.93x
P/FCF (Annual)6.75x
Revenue / Share (TTM)$44.76
ROE (TTM)5.40%
52-Week Low$33.21
vGradeA
gGradeC
mGradeD
vgmGradeC
Show chart for

Earnings Surprise History

Q1 260.89est. 0.84

Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
May 2026
3.67
3.67
2.55
2.55

Industry Peers — Electromedical Equipment(31)

About

CONMED Corporation is a medical technology company that designs and manufactures surgical devices and equipment for multiple specialties, including orthopedic, general, gynecological, thoracic, and gastroenterological procedures. The company serves surgeons and healthcare professionals globally, with operations spanning North America, Europe, the Middle East, Africa, and Asia-Pacific. The United States represents CONMED's largest market and primary revenue driver.